Brainaxy Clinic S.R.L.
- Address
- Strada Muresanu Andrei No. 8, 900348 Constanța, Romania
Immune System Diseases
Clinical research at Brainaxy Clinic S.R.L. in Constanta, Romania focuses strongly on immune-mediated disorders, especially Chronic Inflammatory Demyelinating Polyneuropathy and Generalized Myasthenia Gravis. These studies are designed to evaluate new treatment options, compare effectiveness against existing care, and better understand long-term safety and symptom control.
- Testing new therapies for CIDP to reduce relapse and improve nerve-related function
- Comparing treatment effectiveness in generalized myasthenia gravis to support better disease control
- Assessing safety and tolerability of emerging immune-targeted treatments
Several trials at the site are aimed at helping patients with chronic autoimmune nerve and muscle conditions achieve more stable disease management and improved daily function.
Nervous System Diseases
The site also conducts studies in nervous system diseases, with a particular emphasis on relapsing-remitting multiple sclerosis and Alzheimer’s disease. This research includes efforts to compare new therapies with established options, monitor brain-related disease activity, and explore ways to improve cognitive and neurological outcomes.
- Evaluating a new option for relapsing-remitting multiple sclerosis by comparing disease control and brain lesion activity
- Studying treatments for mild to moderate Alzheimer’s disease to improve thinking skills and overall functioning
- Supporting research into better diagnostics and treatment effectiveness for complex neurological conditions
These trials reflect a broader effort to advance care for people living with chronic disorders of the brain and nervous system.
Mental Disorders
In the area of psychiatry and psychology, the research program includes work related to mental disorders and cognitive impairment, particularly in Alzheimer’s disease. The trials are focused on whether investigational treatments can improve cognition, global functioning, and everyday independence.
- Exploring therapies for cognitive impairment linked to Alzheimer’s disease
- Measuring changes in thinking ability and overall mental functioning
- Advancing treatment approaches that may support better quality of life for patients and caregivers
At Brainaxy Clinic S.R.L., this research area complements the neurological studies by addressing both brain health and the practical impact of cognitive decline.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Immunovant Sciences GmbH2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Immunovant Sciences GmbH3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Brainaxy Clinic S.R.L.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b, Multi-center, Randomized, Double-blind, Placebo controlled Study of IMVT-1402 Treatment in Adult Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Immunovant Sciences GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| IMEROPRUBART | 2 | Unknown | 2025-11-13 | 2025-11-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.